Showing results (211-220 of 241) with videos related to

Sort By:
Pageof 25
Atherosclerosis|September 13, 2011
The SH2B1 obesity locus is associated with myocardial infarction in diabetic patients and with NO synthase activity in endothelial cellsSabrina Prudente, Eleonora Morini, Jay Larmon, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|August 2, 2011
Renal outcomes of agalsidase beta treatment for Fabry disease: role of proteinuria and timing of treatment initiationDavid G Warnock, Alberto Ortiz, Michael Mauer, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|February 5, 2015
Urinary monocyte chemoattractant protein-1 and hepcidin and early diabetic nephropathy lesions in type 1 diabetes mellitusGudeta D Fufaa, E Jennifer Weil, Robert G Nelson, et al.
American Journal of Human Genetics|June 16, 2015
Loss-of-Function Mutations in APPL1 in Familial Diabetes MellitusSabrina Prudente, Prapaporn Jungtrakoon, Antonella Marucci, et al.
Diabetes Care|August 17, 2016
Genetic Predictors of Cardiovascular Mortality During Intensive Glycemic Control in Type 2 Diabetes: Findings From the ACCORD Clinical TrialHetal S Shah, He Gao, Mario Luca Morieri, et al.
Clinical Pharmacology and Therapeutics|July 27, 2026
Disentangling Sex Differences in Sulfonylurea Drug Response With Genome-Wide Association Studies in Individuals With Type 2 DiabetesJoseph H Breeyear, John S House, Mark Kvale, et al.
Molecular Genetics and Metabolism|December 8, 2022
Venglustat, an orally administered glucosylceramide synthase inhibitor: Assessment over 3 years in adult males with classic Fabry disease in an open-label phase 2 study and its extension studyPatrick B Deegan, Ozlem Goker-Alpan, Tarekegn Geberhiwot, et al.
Diabetes Care|September 29, 2018
Genetic Tools for Coronary Risk Assessment in Type 2 Diabetes: A Cohort Study From the ACCORD Clinical TrialMario Luca Morieri, He Gao, Marie Pigeyre, et al.
Molecular Genetics and Metabolism|May 26, 2023
Global reach of over 20 years of experience in the patient-centered Fabry Registry: Advancement of Fabry disease expertise and dissemination of real-world evidence to the Fabry communityChristoph Wanner, Alberto Ortiz, William R Wilcox, et al.
Clinical Pharmacology and Therapeutics|July 25, 2017
Genetic Variants in HSD17B3, SMAD3, and IPO11 Impact Circulating Lipids in Response to Fenofibrate in Individuals With Type 2 DiabetesDaniel M Rotroff, Sonja S Pijut, Skylar W Marvel, et al.
Pageof 25